Clinical trials
Type 2 Diabetes Patients clinical trials
Below are recruiting type 2 diabetes patients clinical trials, each written for real people, not researchers. We’re tracking 571 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT02836808Recruiting
Check a diabetes attention support program for type 2 diabetes
This trial tests an “attention model,” which is a structured way to support your focus and self-management when living with type 2 diabetes. It may help people stay on track with daily care and reduce problems caused by diabetes over time.
Mexico City, Mexico CityAges 18–70 - NCT03463564RecruitingPhase 4
Insulin pump versus insulin shots for type 1 diabetes control
This study compares an insulin pump to insulin shots to see which better improves blood sugar control and reduces swings in people with type 1 diabetes. You may be included if your diabetes is not well controlled despite education and you’ve had low blood sugar episodes.
NaplesAges 18–30 - NCT04932928Recruiting
Using a glucose sensor to improve type 2 diabetes
This study checks whether patient-guided lifestyle changes, supported by a continuous glucose monitor (a sensor), can improve blood sugar control in adults with type 2 diabetes. It may help you and your care team see how food, activity, and habits affect your readings.
SeoulAges 19–80 - NCT04889053Recruiting
CT heart scan study in adults with type 2 diabetes
This trial uses a low-dose CT scan of the heart’s arteries to measure coronary artery calcification in people with type 2 diabetes. It aims to better understand heart calcium buildup and may help improve risk assessment for people with diabetes.
HengyangAges 18 years+ - NCT03865914Recruiting
Study linking diabetes kidney findings to biopsy results
This study looks at people with type 2 diabetes who have kidney problems and relates their symptoms and lab findings to what is seen on kidney biopsy. It may help doctors better understand what is driving kidney damage in diabetes.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05325710Recruiting
Personalized follow-up to help prevent type 2 diabetes
This study tests whether a more personalized check-in plan can help people lower their risk of developing type 2 diabetes. You may be able to get closer guidance focused on your risk level.
Biarritz, AquitaineAges 18–75 - NCT05221359Recruiting
Safety trial of ExOlin® for adults with hard-to-control type 1 diabetes
This trial checks whether ExOlin® is safe in adults with type 1 diabetes who have had difficult blood sugar control or injection-site skin problems despite insulin pump and continuous glucose monitoring. It’s mainly looking for safety and comfort while using the treatment devices.
StrasbourgAges 18 years+ - NCT05553093RecruitingPhase 4
Tirzepatide vs insulin for diabetes and brain effects
This study tests how tirzepatide and insulin glargine affect blood sugar, fat metabolism, and brain function in adults with type 2 diabetes. It may help researchers learn which treatment changes diabetes-related body and brain processes.
Nanjing, JiangsuAges 18–75 - NCT05597709Recruiting
Study diabetes patients to measure MAFLD in Jiangsu
This study checks how common a condition called MAFLD is among people with type 2 diabetes in Jiangsu, China. It may help doctors understand how often this liver-related problem occurs and guide future care for people with type 2 diabetes.
Nanjing, JiangsuAges 18 years+ - NCT04657783Recruiting
French cohort study of people with type 1 diabetes
This study follows people with type 1 diabetes in France to better understand the condition over time. It may help researchers improve future care, especially for how type 1 diabetes starts and is managed from early diagnosis onward.
ParisAges 6–100 - NCT02817360RecruitingPhase 4
Preventing heart events in people with type 2 diabetes
This trial tests a heart-focused prevention approach to lower the risk of cardiac (heart) events in adults with type 2 diabetes. It may help by targeting early stress on the heart measured with a specific blood test.
Mödling, Lower AustriaAges 18 years+ - NCT05363761RecruitingPhase 1
Artery procedure to treat type 2 diabetes and related problems
This Phase 1 study tests a new artery “ablation” procedure for people with type 2 diabetes, aiming to improve diabetes and related conditions like high blood pressure. It will also check whether the procedure is safe and works well enough to study further.
Panama CityAges 21–65 - NCT05369065RecruitingPhase 1
Artery ablation for type 2 diabetes with kidney and liver arteries
This Phase 1 study tests whether a minimally invasive artery procedure can improve type 2 diabetes and related health problems by targeting kidney and liver blood vessels. Because it’s early-stage, the main goal is safety and learning how the treatment works in people who meet specific diabetes, blood pressure, and blood test requirements.
TbilisiAges 21–65 - NCT05888909Recruiting
Tests better diagnosis and treatment planning for kidney disease in type 2 diabetes
This trial focuses on improving how kidney damage is diagnosed and how treatment is planned for people with type 2 diabetes and kidney disease. It may help by using detailed medical history and (if done) kidney biopsy results to guide care more accurately.
BeijingAges 18 years+ - NCT05883072Recruiting
Using AI to support care for people with diabetes in Pakistan
This study tests whether AI-generated support can be helpful for adults living with diabetes. You may be asked to participate if you live in Pakistan and can legally consent.
Karachi, SindhAges 18–100 - NCT06111833Recruiting
Improving Diagnosis and Care for MODY Diabetes
This study looks for a type of diabetes called MODY that runs in families. It aims to improve diagnosis and treatment for people diagnosed with diabetes at a young age.
TaichungAges 18 years+ - NCT06115876Recruiting
Kuwait diabetes long-term follow-up study
This study checks in on people with prediabetes or type 2 diabetes who were part of an earlier Kuwait diabetes study. It aims to understand how their condition has changed and what health care they may need.
Kuwait CityAges 21–75 - NCT04993482Recruiting
Tracks daily movement habits in adults with type 2 diabetes
This study looks at your usual 24-hour movement pattern (like being active, sitting, and sleeping). It may help researchers better understand daily behavior patterns in people with type 2 diabetes.
GhentAges 18–100 - NCT07864168Recruiting
Long-lasting glucose sensor study for type 1 and type 2 diabetes
This study tests a new extended-wear sensor that helps track glucose levels continuously. It is designed to see if a next-generation sensor is accurate and safe for people with diabetes.
Chula Vista, CaliforniaAges 2–80 - NCT05801614Recruiting
Tested diet to help control glucose in early type 2 diabetes
This study tests whether carbohydrate or calorie restriction can help normalize blood sugar levels in people with relatively early type 2 diabetes. It may help those whose diabetes control is not yet fully under control but who do not have major recent heart problems.
StockholmAges 24–70 - NCT03132129Recruiting
Heart imaging study in adults with type 2 diabetes
This study looks for early, “silent” changes in heart function in adults with type 2 diabetes, even if you feel okay. It uses heart scans and looks for factors that may help explain why these changes happen.
LeicesterAges 50–75 - NCT06746714Recruiting
Preventing low blood sugar in high-risk type 2 diabetes
This study tests a program to help people with type 2 diabetes who are at high risk for low blood sugar (hypoglycemia) avoid dangerous drops. It may help you better manage your blood sugar and reduce worrying episodes.
Pleasanton, CaliforniaAges 18 years+ - NCT02973412Recruiting
How sleep timing affects blood sugar in diabetes
This study looks at your daily sleep–wake timing (“chronotype”) and how it may affect blood sugar control in people with diabetes. It may help researchers learn whether sleep patterns could improve glucose levels.
LeicesterAges 18–75 - NCT07873320Enrolling by invitation
Cortisol levels in hard-to-control type 2 diabetes
This study looks for high cortisol levels in people with type 2 diabetes that is difficult to control despite multiple medications. If high cortisol is found, it may point to a condition that can be treated, possibly improving blood sugar control.
Asyut, Asyut GovernorateAges 18–70
Hear when a new Type 2 Diabetes Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 2 diabetes patients?
- Yes. Clin2 currently lists 571 recruiting type 2 diabetes patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 2 diabetes patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 2 diabetes patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.